Advances in immunotherapy in multiple myeloma
Multiple myeloma (MM) is a malignant neoplasm of clonal plasma cells. Incidence of MM is approximately 4/100,000/year, with a slight male predominance.1 Treatment advancements have led to significant improvements in patient outcomes with a 50% increase in overall survival seen in those diagnosed after 1997...
Read more